Annual CAPEX
$1.42 M
-$9.92 M-87.51%
31 December 2023
Summary:
Cytokinetics Incorporated annual capital expenditures is currently $1.42 million, with the most recent change of -$9.92 million (-87.51%) on 31 December 2023. During the last 3 years, it has fallen by -$9.64 million (-87.19%). CYTK annual CAPEX is now -97.10% below its all-time high of $48.87 million, reached on 31 December 2021.CYTK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$701.00 K
-$1.21 M-63.39%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly capital expenditures is currently $701.00 thousand, with the most recent change of -$1.21 million (-63.39%) on 30 September 2024. Over the past year, it has increased by +$481.00 thousand (+218.64%). CYTK quarterly CAPEX is now -96.05% below its all-time high of $17.75 million, reached on 31 December 2021.CYTK Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$2.69 M
+$481.00 K+21.75%
30 September 2024
Summary:
Cytokinetics Incorporated TTM capital expenditures is currently $2.69 million, with the most recent change of +$481.00 thousand (+21.75%) on 30 September 2024. Over the past year, it has dropped by -$1.85 million (-40.74%). CYTK TTM CAPEX is now -94.49% below its all-time high of $48.87 million, reached on 31 December 2021.CYTK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.5% | +218.6% | -40.7% |
| 3 y3 years | -87.2% | -95.5% | -92.8% |
| 5 y5 years | +59.3% | -30.3% | +76.8% |
CYTK CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -97.1% | at low | -96.0% | +810.4% | -94.5% | +90.2% |
| 5 y | 5 years | -97.1% | +59.3% | -96.0% | +810.4% | -94.5% | +90.2% |
| alltime | all time | -97.1% | +1032.8% | -96.0% | +9914.3% | -94.5% | +2859.3% |
Cytokinetics Incorporated CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $701.00 K(-63.4%) | $2.69 M(+21.7%) |
| June 2024 | - | $1.92 M(+2387.0%) | $2.21 M(+56.2%) |
| Dec 2023 | $1.42 M(-87.5%) | $77.00 K(-65.0%) | $1.42 M(-68.8%) |
| Sept 2023 | - | $220.00 K(-69.3%) | $4.54 M(-57.4%) |
| June 2023 | - | $717.00 K(+78.4%) | $10.65 M(-1.3%) |
| Mar 2023 | - | $402.00 K(-87.5%) | $10.79 M(-4.8%) |
| Dec 2022 | $11.34 M(-76.8%) | $3.21 M(-49.4%) | $11.34 M(-56.2%) |
| Sept 2022 | - | $6.33 M(+638.7%) | $25.88 M(-26.6%) |
| June 2022 | - | $857.00 K(-9.0%) | $35.25 M(-18.4%) |
| Mar 2022 | - | $942.00 K(-94.7%) | $43.19 M(-11.6%) |
| Dec 2021 | $48.87 M(+342.2%) | $17.75 M(+13.1%) | $48.87 M(+29.7%) |
| Sept 2021 | - | $15.70 M(+78.6%) | $37.67 M(+53.4%) |
| June 2021 | - | $8.79 M(+32.7%) | $24.57 M(+47.7%) |
| Mar 2021 | - | $6.63 M(+1.1%) | $16.64 M(+50.5%) |
| Dec 2020 | $11.05 M(+322.0%) | $6.55 M(+152.9%) | $11.05 M(+90.5%) |
| Sept 2020 | - | $2.59 M(+200.0%) | $5.80 M(+37.6%) |
| June 2020 | - | $864.00 K(-17.0%) | $4.22 M(+23.9%) |
| Mar 2020 | - | $1.04 M(-20.3%) | $3.40 M(+29.9%) |
| Dec 2019 | $2.62 M(+194.6%) | $1.31 M(+29.8%) | $2.62 M(+72.0%) |
| Sept 2019 | - | $1.01 M(+1912.0%) | $1.52 M(+74.1%) |
| June 2019 | - | $50.00 K(-80.5%) | $875.00 K(-1.1%) |
| Mar 2019 | - | $257.00 K(+22.4%) | $885.00 K(-0.4%) |
| Dec 2018 | $889.00 K(-69.1%) | $210.00 K(-41.3%) | $889.00 K(-39.1%) |
| Sept 2018 | - | $358.00 K(+496.7%) | $1.46 M(-6.0%) |
| June 2018 | - | $60.00 K(-77.0%) | $1.55 M(-11.3%) |
| Mar 2018 | - | $261.00 K(-66.5%) | $1.75 M(-39.2%) |
| Dec 2017 | $2.88 M(+80.3%) | $780.00 K(+72.9%) | $2.88 M(-2.5%) |
| Sept 2017 | - | $451.00 K(+74.8%) | $2.95 M(+5.2%) |
| June 2017 | - | $258.00 K(-81.4%) | $2.81 M(+9.4%) |
| Mar 2017 | - | $1.39 M(+62.5%) | $2.56 M(+60.7%) |
| Dec 2016 | $1.60 M(+184.0%) | $854.00 K(+179.1%) | $1.60 M(+68.7%) |
| Sept 2016 | - | $306.00 K(+1812.5%) | $946.00 K(+36.5%) |
| June 2016 | - | $16.00 K(-96.2%) | $693.00 K(-18.7%) |
| Mar 2016 | - | $420.00 K(+105.9%) | $852.00 K(+51.6%) |
| Dec 2015 | $562.00 K(-49.1%) | $204.00 K(+284.9%) | $562.00 K(-7.1%) |
| Sept 2015 | - | $53.00 K(-69.7%) | $605.00 K(-7.2%) |
| June 2015 | - | $175.00 K(+34.6%) | $652.00 K(-27.6%) |
| Mar 2015 | - | $130.00 K(-47.4%) | $901.00 K(-18.4%) |
| Dec 2014 | $1.10 M(+103.7%) | $247.00 K(+147.0%) | $1.10 M(-0.5%) |
| Sept 2014 | - | $100.00 K(-76.4%) | $1.11 M(+2.9%) |
| June 2014 | - | $424.00 K(+27.3%) | $1.08 M(+54.4%) |
| Mar 2014 | - | $333.00 K(+32.1%) | $698.00 K(+28.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $542.00 K(+333.6%) | $252.00 K(+265.2%) | $542.00 K(+55.3%) |
| Sept 2013 | - | $69.00 K(+56.8%) | $349.00 K(+7.1%) |
| June 2013 | - | $44.00 K(-75.1%) | $326.00 K(+12.8%) |
| Mar 2013 | - | $177.00 K(+200.0%) | $289.00 K(+131.2%) |
| Dec 2012 | $125.00 K(-71.8%) | $59.00 K(+28.3%) | $125.00 K(+37.4%) |
| Sept 2012 | - | $46.00 K(+557.1%) | $91.00 K(-37.7%) |
| June 2012 | - | $7000.00(-46.2%) | $146.00 K(-48.0%) |
| Mar 2012 | - | $13.00 K(-48.0%) | $281.00 K(-36.6%) |
| Dec 2011 | $443.00 K(-10.1%) | $25.00 K(-75.2%) | $443.00 K(-12.3%) |
| Sept 2011 | - | $101.00 K(-28.9%) | $505.00 K(-5.8%) |
| June 2011 | - | $142.00 K(-18.9%) | $536.00 K(+4.3%) |
| Mar 2011 | - | $175.00 K(+101.1%) | $514.00 K(+4.3%) |
| Dec 2010 | $493.00 K(-10.4%) | $87.00 K(-34.1%) | $493.00 K(-20.1%) |
| Sept 2010 | - | $132.00 K(+10.0%) | $617.00 K(+11.2%) |
| June 2010 | - | $120.00 K(-22.1%) | $555.00 K(+14.4%) |
| Mar 2010 | - | $154.00 K(-27.0%) | $485.00 K(-11.8%) |
| Dec 2009 | $550.00 K(-16.4%) | $211.00 K(+201.4%) | $550.00 K(+53.2%) |
| Sept 2009 | - | $70.00 K(+40.0%) | $359.00 K(-0.3%) |
| June 2009 | - | $50.00 K(-77.2%) | $360.00 K(-27.7%) |
| Mar 2009 | - | $219.00 K(+995.0%) | $498.00 K(-24.3%) |
| Dec 2008 | $658.00 K(-74.3%) | $20.00 K(-71.8%) | $658.00 K(-36.4%) |
| Sept 2008 | - | $71.00 K(-62.2%) | $1.03 M(-12.6%) |
| June 2008 | - | $188.00 K(-50.4%) | $1.18 M(-8.1%) |
| Mar 2008 | - | $379.00 K(-4.3%) | $1.29 M(-49.8%) |
| Dec 2007 | $2.56 M(-52.3%) | $396.00 K(+80.0%) | $2.56 M(-32.6%) |
| Sept 2007 | - | $220.00 K(-24.7%) | $3.80 M(-29.8%) |
| June 2007 | - | $292.00 K(-82.4%) | $5.42 M(-11.2%) |
| Mar 2007 | - | $1.66 M(+1.2%) | $6.10 M(+13.6%) |
| Dec 2006 | $5.37 M(+266.6%) | $1.64 M(-11.0%) | $5.37 M(+36.3%) |
| Sept 2006 | - | $1.84 M(+88.8%) | $3.94 M(+56.6%) |
| June 2006 | - | $973.00 K(+5.2%) | $2.52 M(+31.2%) |
| Mar 2006 | - | $925.00 K(+349.0%) | $1.92 M(+30.9%) |
| Dec 2005 | $1.47 M(+4.6%) | $206.00 K(-50.0%) | $1.47 M(-14.4%) |
| Sept 2005 | - | $412.00 K(+10.2%) | $1.71 M(-10.7%) |
| June 2005 | - | $374.00 K(-20.9%) | $1.92 M(+9.7%) |
| Mar 2005 | - | $473.00 K(+4.6%) | $1.75 M(+24.6%) |
| Dec 2004 | $1.40 M(-54.1%) | $452.00 K(-26.6%) | $1.40 M(+47.7%) |
| Sept 2004 | - | $616.00 K(+202.0%) | $948.00 K(+185.5%) |
| June 2004 | - | $204.00 K(+59.4%) | $332.00 K(+159.4%) |
| Mar 2004 | - | $128.00 K | $128.00 K |
| Dec 2003 | $3.05 M(-53.6%) | - | - |
| Dec 2002 | $6.57 M | - | - |
FAQ
- What is Cytokinetics Incorporated annual capital expenditures?
- What is the all time high annual CAPEX for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual CAPEX year-on-year change?
- What is Cytokinetics Incorporated quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly CAPEX year-on-year change?
- What is Cytokinetics Incorporated TTM capital expenditures?
- What is the all time high TTM CAPEX for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM CAPEX year-on-year change?
What is Cytokinetics Incorporated annual capital expenditures?
The current annual CAPEX of CYTK is $1.42 M
What is the all time high annual CAPEX for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual capital expenditures is $48.87 M
What is Cytokinetics Incorporated annual CAPEX year-on-year change?
Over the past year, CYTK annual capital expenditures has changed by -$9.92 M (-87.51%)
What is Cytokinetics Incorporated quarterly capital expenditures?
The current quarterly CAPEX of CYTK is $701.00 K
What is the all time high quarterly CAPEX for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly capital expenditures is $17.75 M
What is Cytokinetics Incorporated quarterly CAPEX year-on-year change?
Over the past year, CYTK quarterly capital expenditures has changed by +$481.00 K (+218.64%)
What is Cytokinetics Incorporated TTM capital expenditures?
The current TTM CAPEX of CYTK is $2.69 M
What is the all time high TTM CAPEX for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM capital expenditures is $48.87 M
What is Cytokinetics Incorporated TTM CAPEX year-on-year change?
Over the past year, CYTK TTM capital expenditures has changed by -$1.85 M (-40.74%)